ABBV

2026Q2BMO

AbbVie Inc primary · HEALTHCARE · DRUG MANUFACTURERS - GENERAL

Report 2026-07-31 · Fiscal end 2026-06-30 · Features as of 2026-07-30

← Earnings history

Pre-Earnings Data

Expectations & setup

Street

Consensus EPS3.64
Consensus rev—
EPS high—
EPS low—
Dispersion—
Analysts—
EPS rev net 7d—
EPS rev net 30d—
Consensus Δ 7d—
Consensus Δ 30d—

Options

Implied move1.7%
IV front—
P/C full—
P/C front—
Features as of2026-07-30

Run-up

Close—
Ret 5d+0.2%
Ret 10d+1.2%
Ret 20d+2.5%
Ret 30d+15.7%

Post-Earnings Data

Results & reaction

Print

Actual EPS
3.65Beat
Estimated EPS3.64
Actual revenue
17.0B
Surprise %+0.3%
Beat / missBeat
Beat streak 41
Beat streak 81

Reaction

1-day stock reaction-0.6%
Implied vs actual

Implied 1.7%Actual 1.9%

Gap reaction-1.9%
Day result-2.5%
Next-day upNo
Realized / IV1.09×

Post tape

Post 5d-2.0%
Post 10d-0.6%
Post volume7.3M
Vol ×10d1.34×
Vol ×20d1.22×
Post range3.4%